TREATMENT OF SMALL VEINS

26
www.sentara.com 8/31/08 1 TREATMENT OF SMALL VEINS CHRISTI SILER, R.N. SENTARA COSMETIC AND LASER TREATMENT CENTER

description

TREATMENT OF SMALL VEINS. SENTARA COSMETIC AND LASER TREATMENT CENTER. CHRISTI SILER, R.N. Examples of Small Veins. Etiology of Venous Disease. Heredity- Primary cause Pregnancy Obesity Standing or sitting for long periods of time Trauma Incidence- 80% female & 20% male. - PowerPoint PPT Presentation

Transcript of TREATMENT OF SMALL VEINS

www.sentara.com

8/31/08 1

TREATMENT OF SMALL VEINS

CHRISTI SILER, R.N.SENTARA COSMETIC AND LASER TREATMENT CENTER

www.sentara.com

8/31/08 2

Examples of Small Veins

www.sentara.com

8/31/08 3

Etiology of Venous Disease

• Heredity- Primary cause

• Pregnancy

• Obesity

• Standing or sitting for long periods of time

• Trauma

• Incidence- 80% female & 20% male

www.sentara.com

8/31/08 4

Microanatomy of Venous System

Spider Veins

Reticular Vein

Perforator

www.sentara.com

8/31/08 5

Algorithm for Small Vessel Treatment

• Rule out truncal insufficiency- plan to correct if present

• Determine system involved

• Identify associated reticular veins

• Perform appropriate treatment

• Compression for 5-7 days

• Follow-up & re-treat in 4-6 weeks

www.sentara.com

8/31/08 6

Lateral Reticular Vein with associated telangiectasia

www.sentara.com

8/31/08 7

Small Vein Treatment Options

• Sclerotherapy- still the Gold Standard

• Lasers- great adjunct to treatment

• Non lasers- IPL, Ohmic Thermolysis, Vascutouch

• Microphlebectomy- for large reticular veins

• Combination Therapy- BEST OPTION for quickest and cosmetically superior results

www.sentara.com

8/31/08 8

The Ideal Sclerosant

• Non-allergenic/ Non-toxic

• Painless• No risk of

hyperpigmentation• No risk of telangiectatic

matting• No ulceration• FDA approved

• UNFORTUNATELY, no sclerosant meets all of this criteria

www.sentara.com

8/31/08 9

Detergent Properties

• Efficient sclerosant- causes intimal inflammation thrombus formation fibrous tissue vein obliteration

• Painless

• Low rate of allergies

• Low rate of pigmentation

• Extravasation tolerated at low amounts

www.sentara.com

8/31/08 10

Reticular Veins

• R/O truncal insufficiency/ incompetent perforators

• Inject reticular veins first

• Follow with laser/ sclerotherapy to telangiectasias

• Compression dressing post tx facilitates clotting

www.sentara.com

8/31/08 11

Why Combination Therapy?

Vessel damage d/t heat

Laser spider veins first

Decreased intimal lumen

Less sclerosant neededLower incidence of hyperpigmentation

TWICE THE DAMAGE MEANS TWICE AS FAST!

www.sentara.com

8/31/08 12

Lasers- Not All are Created Equal

• 940 nm and 1064 nm most common for treatment of telangiectasias

• Goal is to cause vessel damage without damaging surrounding tissue

• No sun exposure or sunless tanning prior to tx

• Test laser and sclerotherapy at consultation to assess response and candidacy for treatment

www.sentara.com

8/31/08 13

Superior Cosmetic Result with Combination Therapy

www.sentara.com

8/31/08 14

www.sentara.com

8/31/08 15

Foam Sclerotherapy

• CO2 vs. Room Air– CO2 bubbles dissolves faster in arterial

circulation, thus reducing the risk of adverse event

• Tessari Method-– 1 part solution: 4 parts

gas– Stopcock, 2 syringes

www.sentara.com

8/31/08 16

Foam Sclerotherapy

www.sentara.com

8/31/08 17

•Advantages-•Increases surface area of sclerosant, thus reducing amount

of drug needed

•Circumferential contact with intimal wall causes more damage/

better result

•Displaces blood, thus avoiding dilution of drug/ increases efficacy

•Disadvantages-•Patients with PFO may not be candidate

•Neurological deficits-•Migraine•Scotoma

•DVT- clear deep system with foot dorsiflexion immediately post tx and encourage ambulation

www.sentara.com

a

8/31/08 18

www.sentara.com

8/31/08 19

Before/ After Foam Sclerotherapy

www.sentara.com

6 Weeks After One Treatment!

8/31/08 20

www.sentara.com

8/31/08 21

www.sentara.com

Facial Telangiectasias

8/31/08 22

www.sentara.com

Adverse Sequelae

• Post Sclerotherapy Hyperpigmentation- transient

• Localized Urticaria d/t inflammatory response/ histamine release

• Angiogenesis/ Telangiectatic Matting- R/O truncal insufficiency or perforators to decrease risk

• Discomfort at injection site

• Recurrence- hereditary8/31/08 23

www.sentara.com

Complications

• Cutaneous necrosis

• Superficial thrombophlebitis

• DVT

• Nerve Injury

• Allergic Reaction

• Migraine

• Scotoma

8/31/08 24

www.sentara.com

8/31/08 25

www.sentara.com

In Summary• Reticular veins & associated telangiectasia can be

easily treated in the office setting

• R/O truncal insufficiency or incompetent perforators

• Microphlebectomy if needed for large reticular veins

• Laser/ RF first and follow with sclerotherapy

• Foam sclerotherapy to reticular veins if appropriate candidate

• Dilute sclerotherapy to telangiectasia

• Most patients require 3-5 treatments spaced 4-6 weeks apart for optimal results

8/31/08 26